Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|December 20, 2011
A simplified intravenous artesunate regimen for severe malariaPeter Gottfried Kremsner, Terrie Taylor, Saadou Issifou, et al.
Plos One|August 7, 2010
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in AsiaNeena Valecha, Aung Pyae Phyo, Mayfong Mayxay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2018
Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in GabonGhyslain Mombo-Ngoma, Jonathan Remppis, Moritz Sievers, et al.
Pharmacogenetics and Genomics|May 21, 2020
Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malariaPamela L St Jean, Gavin C K W Koh, John J Breton, et al.
BMC Medicine|October 10, 2017
A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malariaFiona Macintyre, Yeka Adoke, Alfred B Tiono, et al.
Malaria Journal|January 3, 2023
Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malariaAdama Gansane, Moussa Lingani, Adoke Yeka, et al.
Drug Safety|June 13, 2019
Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy VolunteersJessica Ackert, Khadeeja Mohamed, Jason S Slakter, et al.
The Lancet. Infectious Diseases|June 18, 2018
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a studyAlejandro Llanos-Cuentas, Martin Casapia, Raúl Chuquiyauri, et al.
Malaria Journal|May 9, 2021
Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countriesNicolas Vignier, Olivier Bouchaud, Andrea Angheben, et al.
The Lancet. Global Health|February 16, 2024
Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysisMarcelo Brito, Rosilene Rufatto, Felipe Murta, et al.
Pageof 10